Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
Status:
Completed
Trial end date:
2018-11-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if telmisartan is effective in slowing the
progression of abdominal aortic aneurysms and reducing circulating concentrations of
Abdominal Aortic Aneurysms (AAA) biomarkers.
Phase:
Phase 4
Details
Lead Sponsor:
Palo Alto Veterans Institute for Research Ronald L. Dalman, MD
Collaborators:
James Cook University, Queensland, Australia Medtronic